Commonwealth Equity Services, LLC Lannett CO Inc Transaction History

Commonwealth Equity Services, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$2.91 - $4.83 $120,296 - $199,667	-41,339 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$4.17 - $5.74 $57,295 - $78,867	13,740 Added 49.78%	41,339 $193,000
Q1 2021 May 04, 2021	SELL	$5.28 - $9.64 $46,770 - $85,391	-8,858 Reduced 24.3%	27,599 $145,000
Q4 2020 Feb 11, 2021	BUY	$5.75 - $7.13 $50,214 - $62,266	8,733 Added 31.5%	36,457 $237,000
Q3 2020 Nov 05, 2020	SELL	$4.9 - $7.12 $33,202 - $48,245	-6,776 Reduced 19.64%	27,724 $169,000
Q2 2020 Aug 12, 2020	SELL	$6.43 - $9.86 $22,183 - $34,017	-3,450 Reduced 9.09%	34,500 $250,000
Q1 2020 May 11, 2020	BUY	$6.36 - $10.05 $65,024 - $102,751	10,224 Added 36.88%	37,950 $263,000
Q4 2019 Feb 05, 2020	BUY	$8.49 - $12.81 $150,128 - $226,519	17,683 Added 176.07%	27,726 $244,000
Q3 2019 Oct 30, 2019	SELL	$5.58 - $14.47 $90,675 - $235,137	-16,250 Reduced 61.8%	10,043 $112,000
Q2 2019 Jul 19, 2019	BUY	$5.22 - $9.08 $84,433 - $146,869	16,175 Added 159.86%	26,293 $159,000
Q1 2019 May 13, 2019	BUY	$5.35 - $9.82 $54,131 - $99,358	10,118 New	10,118 $79,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.